Essa Pharma Inc Expected To Post A Loss Of 28 Cents A Share: Earnings Preview

ESSA Pharma

14/11/2022 12:02

* ESSA Pharma Inc  EPIX.OQ   EPIX.O  is expected to show no
change
in quarterly revenue when it reports  results on November 16
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for ESSA Pharma Inc is
for a
loss of 28 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ESSA Pharma
Inc
is $23​, above​ its last closing price of $3.67. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.28       -0.27      -0.20     Beat    25.9
 Mar. 31 2022  -0.26       -0.25      -0.25     Met     1
 Dec. 31 2021  -0.23       -0.23      -0.21     Beat    8.7​
 Sep. 30 2021  -0.22       -0.23      -0.20     Beat    14
 ​​Jun.        -0.26       -0.26      -0.21     Beat    20
 30 2021                                                
 Mar. 31 2021  -0.21       -0.21      -0.36     Missed  -68.2​
 Dec. 31 2020  -0.17       -0.17      -0.20     Missed  -17.6
 Sep. 30 2020  -0.20       -0.19      -0.13     Beat    33.3
 This summary was machine generated November 14 at 12:02 GMT. 
All figures in US dollars  unless otherwise stated